MX2020002777A - Metodos y composiciones para tratamiento de epidermolisis ampollosa. - Google Patents

Metodos y composiciones para tratamiento de epidermolisis ampollosa.

Info

Publication number
MX2020002777A
MX2020002777A MX2020002777A MX2020002777A MX2020002777A MX 2020002777 A MX2020002777 A MX 2020002777A MX 2020002777 A MX2020002777 A MX 2020002777A MX 2020002777 A MX2020002777 A MX 2020002777A MX 2020002777 A MX2020002777 A MX 2020002777A
Authority
MX
Mexico
Prior art keywords
methods
compositions
treatment
epidermolysis bullosa
bullosa
Prior art date
Application number
MX2020002777A
Other languages
English (en)
Spanish (es)
Inventor
Evangelos V Badiavas
Original Assignee
Univ Miami
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US15/712,294 external-priority patent/US20180104186A1/en
Application filed by Univ Miami filed Critical Univ Miami
Publication of MX2020002777A publication Critical patent/MX2020002777A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5063—Compounds of unknown constitution, e.g. material from plants or animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Virology (AREA)
  • Toxicology (AREA)
  • Botany (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Physical Water Treatments (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
MX2020002777A 2017-09-22 2018-09-21 Metodos y composiciones para tratamiento de epidermolisis ampollosa. MX2020002777A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15/712,294 US20180104186A1 (en) 2013-03-13 2017-09-22 Methods and compositions for the treatment of epidermolysis bullosa
PCT/US2018/052213 WO2019060719A1 (en) 2017-09-22 2018-09-21 METHODS AND COMPOSITIONS FOR THE TREATMENT OF BULLETIN EPIDERMOLYSIS

Publications (1)

Publication Number Publication Date
MX2020002777A true MX2020002777A (es) 2020-09-17

Family

ID=65810503

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2020002777A MX2020002777A (es) 2017-09-22 2018-09-21 Metodos y composiciones para tratamiento de epidermolisis ampollosa.
MX2022015753A MX2022015753A (es) 2017-09-22 2020-03-12 Metodos y composiciones para tratamiento de epidermolisis ampollosa.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2022015753A MX2022015753A (es) 2017-09-22 2020-03-12 Metodos y composiciones para tratamiento de epidermolisis ampollosa.

Country Status (10)

Country Link
EP (1) EP3684336A4 (ru)
JP (1) JP2020534344A (ru)
KR (1) KR20200088799A (ru)
CN (1) CN111182890A (ru)
AU (1) AU2018335788A1 (ru)
CA (1) CA3076610A1 (ru)
EA (1) EA202090814A1 (ru)
IL (1) IL273407A (ru)
MX (2) MX2020002777A (ru)
WO (1) WO2019060719A1 (ru)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10640464B2 (en) 2011-01-03 2020-05-05 The William M. Yarbrough Foundation Use of isothiocyanate functional surfactants as Nrf2 inducers to treat epidermolysis bullosa simplex and related diseases
KR102125567B1 (ko) * 2019-07-02 2020-06-22 한양대학교 에리카산학협력단 식물 엑소좀의 대량 생산 방법
WO2022018884A1 (ja) * 2020-07-22 2022-01-27 国立大学法人大阪大学 栄養障害型表皮水疱症の治療薬
MX2023001927A (es) * 2020-08-21 2023-03-09 Univ Miami Composiciones y metodos de tratamiento usando microvesiculas de celulas madre mesenquimaticas derivadas de medula osea.
EP3971440B1 (en) 2020-09-21 2023-12-27 Brembo S.p.A. Braking band of a disc brake disc and disc brake disc
CN118076583A (zh) * 2021-08-12 2024-05-24 安可诺瓦治疗公司 用于治疗癌症的方法和组合物
WO2023064819A1 (en) * 2021-10-12 2023-04-20 Eliksa Therapeutics, Inc. Methods of treating epidermolysis bullosa with cell-free amniotic fluid compositions

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT3677271T (pt) * 2013-03-13 2023-05-31 Univ Miami Método de isolamento e purificação de microvesículas de sobrenadantes de cultura celular e fluidos biológicos
WO2015038075A1 (en) * 2013-09-16 2015-03-19 Agency For Science, Technology And Research Method
US20170173113A1 (en) * 2014-03-13 2017-06-22 Research Institute At Nationwide Children's Hospital Methods of delivering heparin binding epidermal growth factor using stem cell generated exosomes
WO2016172598A1 (en) * 2015-04-22 2016-10-27 The Broad Institute Inc. Exosomes and uses thereof
KR20170085010A (ko) * 2016-01-12 2017-07-21 주식회사 강스템바이오텍 고함량의 성장인자를 함유한 줄기세포 유래 엑소좀
WO2017122095A1 (en) * 2016-01-15 2017-07-20 Orbsen Therapeutics Limited Sdc-2 exosome compositions and methods of isolation and use

Also Published As

Publication number Publication date
MX2022015753A (es) 2023-01-19
KR20200088799A (ko) 2020-07-23
CA3076610A1 (en) 2019-03-28
JP2020534344A (ja) 2020-11-26
EA202090814A1 (ru) 2020-08-07
EP3684336A4 (en) 2021-06-02
EP3684336A1 (en) 2020-07-29
WO2019060719A1 (en) 2019-03-28
CN111182890A (zh) 2020-05-19
AU2018335788A1 (en) 2020-03-19
IL273407A (en) 2020-05-31

Similar Documents

Publication Publication Date Title
MX2022015753A (es) Metodos y composiciones para tratamiento de epidermolisis ampollosa.
MX2018011114A (es) Métodos y composiciones relacionadas con crispr/cas para el tratamiento de beta hemoglobinopatías.
SG11202010830WA (en) Methods of treating phenylketonuria
MX2023007841A (es) Metodos, composiciones y componentes relacionados con crispr-cpf1 para la inmunoterapia contra el cancer.
IL275663A (en) Cancer treatment methods
MX2019003623A (es) Composiciones y metodos para el tratamiento de afecciones oftalmicas.
MX2019001471A (es) Anticuerpos anti-siglec-7 para el tratamiento del cancer.
MX2020001774A (es) Composiciones y métodos para tratar enfermedad colestásica.
IL268814A (en) Preparations and methods for the treatment of cancer
MX2018009325A (es) Compuestos y metodos para tratar enfermedades mediadas por el acido ribonucleico (arn).
PH12017501864A1 (en) Compositions and methods for treating autism
MX2017016114A (es) Metodos para tratar o prevenir una proteopatia.
IL286297A (en) Minimal residual cancer treatment methods
IL263697A (en) Compounds, preparations and methods for the treatment and/or prevention of cancer
MX2020006297A (es) Variantes de cd19.
IL268163A (en) Methods, compositions, and kits for treatment of cancer
EP3634422A4 (en) LEUKODYSTROPHY TREATMENT METHODS
SG11202012055PA (en) Methods and compositions for preventing or treating calciphylaxis
SG11202010793UA (en) Methods of treating cancer
IL280721A (en) A method for treating relapse of follicular lymphoma
IL276203A (en) Compounds and methods for treating cancer
MX2022011897A (es) Composicion intraarticular para el tratamiento del cartilago y la artritis.
AU2016323967A8 (en) Compositions and methods for the treatment and prevention of radiation dermatitis
SG11202005163PA (en) Methods of treating cancer
IL281600A (en) Methods of treating cancer